Wedbush Starts Aquestive Therapeutics (AQST) at Outperform
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Price: $4.25 --0%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst Liana Moussatos initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) with a Outperform rating and a price target of $33.00.
For an analyst ratings summary and ratings history on Aquestive Therapeutics click here. For more ratings news on Aquestive Therapeutics click here.
Shares of Aquestive Therapeutics closed at $18.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aquestive reports study results for Anaphylm ahead of NDA resubmission
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Liana MoussatosSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
